Search research articles
Contact Us
Filters
Showing results (311-320 of 529) with videos related to
Page
of 53
Sort By:
Endocrinology
|
April 5, 2008
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression
Ivan Tancevski, Andreas Wehinger, Egon Demetz, et al.
Scientific Reports
|
March 30, 2020
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
Maria Dumitrascuta, Marcel Bermudez, Tanila Ben Haddou, et al.
Atherosclerosis
|
June 8, 2007
Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis
Wilfried Schgoer, Thomas Mueller, Matti Jauhiainen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 27, 2009
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance
Barbara Messner, Michael Knoflach, Andreas Seubert, et al.
Atherosclerosis
|
April 13, 2012
Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits
Egon Demetz, Ivan Tancevski, Kristina Duwensee, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
December 2, 2020
A sensitivity leap for X-band EPR using a probehead with a cryogenic preamplifier
Mantas Šimėnas, James O'Sullivan, Christoph W Zollitsch, et al.
European Radiology
|
July 29, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study
Maximilian Merz, Thomas M Moehler, Judith Ritsch, et al.
Journal of Molecular and Cellular Cardiology
|
August 8, 2016
Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- mice
Bernhard Scharinger, Barbara Messner, Adrian Türkcan, et al.
Metabolism: Clinical and Experimental
|
July 10, 2007
Scavenger receptor class B type I polymorphisms and peripheral arterial disease
Andreas Ritsch, Gudrun Sonderegger, Gudron Sonderegger, et al.
Atherosclerosis
|
August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
Kristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Page
of 53
Search research articles
Search
Showing results (311-320 of 529) with videos related to
Sort By:
Page
of 53
Endocrinology
|
April 5, 2008
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression
Ivan Tancevski, Andreas Wehinger, Egon Demetz, et al.
Scientific Reports
|
March 30, 2020
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
Maria Dumitrascuta, Marcel Bermudez, Tanila Ben Haddou, et al.
Atherosclerosis
|
June 8, 2007
Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis
Wilfried Schgoer, Thomas Mueller, Matti Jauhiainen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 27, 2009
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance
Barbara Messner, Michael Knoflach, Andreas Seubert, et al.
Atherosclerosis
|
April 13, 2012
Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits
Egon Demetz, Ivan Tancevski, Kristina Duwensee, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
December 2, 2020
A sensitivity leap for X-band EPR using a probehead with a cryogenic preamplifier
Mantas Šimėnas, James O'Sullivan, Christoph W Zollitsch, et al.
European Radiology
|
July 29, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study
Maximilian Merz, Thomas M Moehler, Judith Ritsch, et al.
Journal of Molecular and Cellular Cardiology
|
August 8, 2016
Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- mice
Bernhard Scharinger, Barbara Messner, Adrian Türkcan, et al.
Metabolism: Clinical and Experimental
|
July 10, 2007
Scavenger receptor class B type I polymorphisms and peripheral arterial disease
Andreas Ritsch, Gudrun Sonderegger, Gudron Sonderegger, et al.
Atherosclerosis
|
August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
Kristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Page
of 53